Sponsors Want Answers On Consequences Of Missing US FDA Trial Diversity Goals

diversity
Sponsors are hoping clinical trial diversity guidance updates will include more clarity on FDA actions when enrollment goals are missed. • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Diversity & Inclusion

More from Clinical Trials